United States · FDA National Drug Code directory

Zolpidem Tartrate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76420-496_ea435212-caf8-164b-e053-2a95a90a0bf6
Product NDC
76420-496
Form
TABLET, EXTENDED RELEASE
Composition / generic term
Zolpidem Tartrate
Labeler
Asclemed USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20201217
Source listing expiry
20261231

Source-listed ingredients

  • ZOLPIDEM TARTRATE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-496-01) · 76420-496-01
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-496-30) · 76420-496-30
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-496-60) · 76420-496-60
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76420-496-90) · 76420-496-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →